A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma

A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma

Xehetasun bibliografikoak
Egile Nagusiak:	Midgley, R, Kerr, D, Palmer, D, Mirza, N, Milner, A, Adams, D
Formatua:	Journal article
Argitaratua:	2004

Antzeko izenburuak

A phase I/II dendritic cell (DC) immunotherapy trial for hepatocellular carcinoma (HC)
nork: Midgley, R, et al.
Argitaratua: (2002)

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.
nork: Palmer, D, et al.
Argitaratua: (2009)

Dendritic cell vaccination for hepatocellular carcinoma.
nork: Midgley, R, et al.
Argitaratua: (2003)

Adjuvant immunotherapy with autologous dendritic cells for hepatocellular carcinoma, randomized phase II study
nork: Jeong-Hoon Lee, et al.
Argitaratua: (2017-07-01)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
nork: Raquel S Laureano, et al.
Argitaratua: (2022-12-01)

Immunotherapy for colorectal cancer: a challenge to clinical trial design.
nork: Midgley, R, et al.
Argitaratua: (2000)

Immunotherapy for colorectal cancer.
nork: Midgley, R, et al.
Argitaratua: (2003)

Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy
nork: Shao-Li Huang, et al.
Argitaratua: (2021-07-01)

Thymostimulin in advanced hepatocellular carcinoma: A phase II trial
nork: Behl Susanne, et al.
Argitaratua: (2008-03-01)

Immunotherapy for colorectal cancer: potential application in an adjuvant setting.
nork: Kerr, D, et al.
Argitaratua: (2000)

Immunotherapy for colorectal cancer: Potential application in an adjuvant setting
nork: Kerr, D, et al.
Argitaratua: (2000)

Immunotherapy for hepatocellular carcinoma
nork: Xiaoxia Wang, et al.
Argitaratua: (2024-08-01)

Immunotherapy in hepatocellular carcinoma
nork: Luigi Buonaguro, et al.
Argitaratua: (2019-03-01)

Trial watch: Dendritic cell-based anticancer immunotherapy
nork: Abhishek D. Garg, et al.
Argitaratua: (2017-07-01)

Trial watch: dendritic cell vaccination for cancer immunotherapy
nork: Jenny Sprooten, et al.
Argitaratua: (2019-11-01)

Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
nork: Feun LG, et al.
Argitaratua: (2018-01-01)

Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation
nork: Zecong Xiao, et al.
Argitaratua: (2023-03-01)

T Cell–Associated Immunotherapy for Hepatocellular Carcinoma
nork: Weijie Ma, et al.
Argitaratua: (2017-02-01)

Activation of human dendritic cells for immunotherapy in ovarian carcinoma
nork: Brencicova, E, et al.
Argitaratua: (2012)

A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma
nork: Dae-Won Lee, et al.
Argitaratua: (2018-03-01)

Immunotherapies for advanced hepatocellular carcinoma
nork: Li-Yang Sun, et al.
Argitaratua: (2023-03-01)

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma
nork: Marron TU, et al.
Argitaratua: (2022-06-01)

Editorial: Immunotherapy in Hepatocellular Carcinoma
nork: Bin Li, et al.
Argitaratua: (2021-06-01)

Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma
nork: Manfredi GF, et al.
Argitaratua: (2023-11-01)

Comparison of monocyte versus CD34+precursors for the generation of clinical grade dendritic cells for immunotherapy protocols in hepatocellular carcinoma
nork: Daniels, H, et al.
Argitaratua: (2005)

Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation Profiling
nork: Robin K. Kelley, et al.
Argitaratua: (2021-09-01)

Immune cell infiltration and immunotherapy in hepatocellular carcinoma
nork: Yu Jiang, et al.
Argitaratua: (2022-05-01)

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
nork: Apostolos Sarivalasis, et al.
Argitaratua: (2019-11-01)

Understanding Dendritic Cells and Their Role in Cutaneous Carcinoma and Cancer Immunotherapy
nork: Valerie R. Yanofsky, et al.
Argitaratua: (2013-01-01)

Post-operative adjuvant immunotherapy with cytokine-induced killer and dendritic cells for hepatocellular carcinoma: A systematic review and meta-analysis
nork: Huijun Guo, et al.
Argitaratua: (2023-06-01)

Immunotherapy for hepatocellular carcinomaKey points
nork: Alexa Childs, et al.
Argitaratua: (2024-10-01)

Complications of immunotherapy in advanced hepatocellular carcinoma
nork: Young-Gi Song, et al.
Argitaratua: (2024-03-01)

Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
nork: Fuat Bicer, et al.
Argitaratua: (2023-11-01)

Inflammatory microenvironment and immunotherapy in hepatocellular carcinoma
nork: Liwei Liu, et al.
Argitaratua: (2023-04-01)

Bibliometric study of immunotherapy for hepatocellular carcinoma
nork: Zhiyi Li, et al.
Argitaratua: (2023-08-01)

Phase II trial of sorafenib and doxorubicin in patients with advanced hepatocellular carcinoma after disease progression on sorafenib
nork: Imane El Dika, et al.
Argitaratua: (2020-10-01)

Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
nork: Wenya Li, et al.
Argitaratua: (2024-09-01)

319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine
nork: Gabriel Nistor, et al.
Argitaratua: (2020-11-01)

Demographics and Immunotherapy Efficacy for Advanced Hepatocellular carcinoma: A Systematic Review and Meta-Analysis of Phase III Clinical Trials
nork: Yu-Yun Shao, et al.
Argitaratua: (2024-11-01)

Donafenib combined with sintilimab for advanced hepatocellular carcinoma: a single arm phase II trial
nork: Xiaoyang Hong, et al.
Argitaratua: (2025-02-01)